IgM predominance in autoimmune disease: Genetics and gender

Autoimmunity Reviews

Volumn 11, Issue 6-7, 2012, Pages

  Duarte Rey, Carolina ^a,b,c   Bogdanos, Dimitrios P ^d   Leung, Patrick S C ^a   Anaya, Juan Manuel ^c   Gershwin, M Eric ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b PONTIFICIA UNIVERSIDAD JAVERIANA   (Colombia)

^c UNIVERSIDAD DEL ROSARIO   (Colombia)

^d KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Autoimmune disease; Autoimmune hemolytic anemia; Cryoglobulinemia; Immunoglobulin M; Multiple sclerosis; Primary biliary cirrhosis

Indexed keywords

ACTIVATION INDUCED CYTIDINE DEAMINASE; ALPHA INTERFERON; ANTINUCLEAR ANTIBODY; ANTIVIRUS AGENT; CD40 ANTIGEN; CD40 LIGAND; COMPLEMENT COMPONENT C3B; I KAPPA B KINASE GAMMA; IMMUNOGLOBULIN; IMMUNOGLOBULIN M; RHEUMATOID FACTOR; RITUXIMAB; SMOOTH MUSCLE ANTIBODY; THYROID HORMONE;

ANTIVIRAL THERAPY; ARTHRITIS; AUTOIMMUNE DISEASE; AUTOIMMUNE HEMOLYTIC ANEMIA; AUTOIMMUNE HEPATITIS; AUTOIMMUNE THROMBOCYTOPENIA; AUTOIMMUNE THYROIDITIS; B LYMPHOCYTE; CD4+ T LYMPHOCYTE; CELL SELECTION; CHRONIC DIARRHEA; COOMBS POSITIVE HEMOLYTIC ANEMIA; CRYOGLOBULINEMIA; DISCOID LUPUS ERYTHEMATOSUS; ENTERITIS; GENDER; GENE EXPRESSION; GENE MUTATION; HASHIMOTO DISEASE; HEPATITIS C; HORMONE SUBSTITUTION; HUMAN; HYPER IGM SYNDROME; HYPOTHYROIDISM; IMMUNOGLOBULIN M DEFICIENCY; INFECTION; INTERSTITIAL PNEUMONIA; KARYOTYPE 47,XXX; LIVER INJURY; LYMPHOPROLIFERATIVE DISEASE; MULTIPLE SCLEROSIS; NEPHRITIS; NONHUMAN; PLASMAPHERESIS; PRIMARY BILIARY CIRRHOSIS; REVIEW; RHEUMATOID ARTHRITIS; STEM CELL TRANSPLANTATION; SYSTEMIC LUPUS ERYTHEMATOSUS; X CHROMOSOME;

AUTOIMMUNE DISEASES; B-LYMPHOCYTES; FEMALE; HUMANS; HYPER-IGM IMMUNODEFICIENCY SYNDROME; IMMUNOGLOBULIN M; MALE; SEX FACTORS;

EID: 84858438893     PISSN: 15689972     EISSN: 18730183     Source Type: Journal    
DOI: 10.1016/j.autrev.2011.12.001     Document Type: Review

References (119)

1. Raju T.N. The Nobel chronicles. 1972: Gerald M Edelman (b 1929) and Rodney R Porter (1917-85). Lancet 1999, 354:1040.
2. Ehrenstein M.R., Notley C.A. The importance of natural IgM: scavenger, protector and regulator. Nat Rev Immunol 2010, 10:778-786.
3. Brandlein S., Pohle T., Ruoff N., Wozniak E., Muller-Hermelink H.K., Vollmers H.P. Natural IgM antibodies and immunosurveillance mechanisms against epithelial cancer cells in humans. Cancer Res 2003, 63:7995-8005.
4. Schwartz-Albiez R., Monteiro R.C., Rodriguez M., Binder C.J., Shoenfeld Y. Natural antibodies, intravenous immunoglobulin and their role in autoimmunity, cancer and inflammation. Clin Exp Immunol 2009, 158(Suppl. 1):43-50.
5. Ben-Aissa-Fennira F., Ben Ammar-El Gaaied A., Bouguerra A., Dellagi K. IgM antibodies to P1 cytoadhesin of Mycoplasma pneumoniae are part of the natural antibody repertoire expressed early in life. Immunol Lett 1998, 63:59-62.
6. Boes M., Prodeus A.P., Schmidt T., Carroll M.C., Chen J. A critical role of natural immunoglobulin M in immediate defense against systemic bacterial infection. J Exp Med 1998, 188:2381-2386.
7. Catellani S., Pierri I., Gobbi M., Poggi A., Zocchi M.R. Imatinib treatment induces CD5+ B lymphocytes and IgM natural antibodies with anti-leukemic reactivity in patients with chronic myelogenous leukemia. PLoS One 2011, 6:e18925.
8. Ochsenbein A.F., Fehr T., Lutz C., Suter M., Brombacher F., Hengartner H., et al. Control of early viral and bacterial distribution and disease by natural antibodies. Science 1999, 286:2156-2159.
9. Vollmers H.P., Brandlein S. Natural IgM antibodies: the orphaned molecules in immune surveillance. Adv Drug Deliv Rev 2006, 58:755-765.
10. Boes M., Esau C., Fischer M.B., Schmidt T., Carroll M., Chen J. Enhanced B-1 cell development, but impaired IgG antibody responses in mice deficient in secreted IgM. J Immunol 1998, 160:4776-4787.
11. Ehrenstein M.R., O'Keefe T.L., Davies S.L., Neuberger M.S. Targeted gene disruption reveals a role for natural secretory IgM in the maturation of the primary immune response. Proc Natl Acad Sci U S A 1998, 95:10089-10093.
12. Griffin D.O., Holodick N.E., Rothstein T.L. Human B1 cells in umbilical cord and adult peripheral blood express the novel phenotype CD20+ CD27+ CD43+ CD70. J Exp Med 2011, 208:67-80.
13. Fecteau J.F., Cote G., Neron S. A new memory CD27-IgG+ B cell population in peripheral blood expressing VH genes with low frequency of somatic mutation. J Immunol 2006, 177:3728-3736.
14. Choi Y.S., Dieter J.A., Rothaeusler K., Luo Z., Baumgarth N. B-1 cells in the bone marrow are a significant source of natural IgM. Eur J Immunol. 2011 Oct 18, doi:10.1002/eji.201141890. [Electronic publication ahead of print].
15. Xu H., Roberts-Thomson P.J. Circulating low molecular weight IgM-a disease marker in autoimmune, infective, immunodeficient and B cell lymphoproliferative disorders. Dis Markers 1992, 10:115-141.
16. Brewer J.W., Randall T.D., Parkhouse R.M., Corley R.B. Mechanism and subcellular localization of secretory IgM polymer assembly. J Biol Chem 1994, 269:17338-17348.
17. Hughey C.T., Brewer J.W., Colosia A.D., Rosse W.F., Corley R.B. Production of IgM hexamers by normal and autoimmune B cells: implications for the physiologic role of hexameric IgM. J Immunol 1998, 161:4091-4097.
18. Limnander A., Depeille P., Freedman T.S., Liou J., Leitges M., Kurosaki T., et al. STIM1, PKC-delta and RasGRP set a threshold for proapoptotic Erk signaling during B cell development. Nat Immunol 2011, 12:425-433.
19. Zuckerman N.S., Hazanov H., Barak M., Edelman H., Hess S., Shcolnik H., et al. Somatic hypermutation and antigen-driven selection of B cells are altered in autoimmune diseases. J Autoimmun 2010, 35:325-335.
20. Murphy K., Travers P., Walport M. Janneway's immunobiology 2007, Garland Publishing, New York. Seventh ed.
21. Morbach H., Singh S.K., Faber C., Lipsky P.E., Girschick H.J. Analysis of RAG expression by peripheral blood CD5+ and CD5-B cells of patients with childhood systemic lupus erythematosus. Ann Rheum Dis 2006, 65:482-487.
22. Srinivas S.K., Sixbey J.W. Epstein-Barr virus induction of recombinase-activating genes RAG1 and RAG2. J Virol 1995, 69:8155-8158.
23. Rhodes K., Markham R.L., Maxwell P.M., Monk-Jones M.E. Immunoglobulins and the X-chromosome. Br Med J 1969, 3:439-441.
24. Miga A., Masters S., Gonzalez M., Noelle R.J. The role of CD40-CD154 interactions in the regulation of cell mediated immunity. Immunol Invest 2000, 29:111-114.
25. Grewal I.S., Flavell R.A. CD40 and CD154 in cell-mediated immunity. Annu Rev Immunol 1998, 16:111-135.
26. Banatvala N., Davies J., Kanariou M., Strobel S., Levinsky R., Morgan G. Hypogammaglobulinaemia associated with normal or increased IgM (the hyper IgM syndrome): a case series review. Arch Dis Child 1994, 71:150-152.
27. Davies E.G., Thrasher A.J. Update on the hyper immunoglobulin M syndromes. Br J Haematol 2010, 149:167-180.
28. Kracker S., Gardes P., Mazerolles F., Durandy A. Immunoglobulin class switch recombination deficiencies. Clin Immunol 2010, 135:193-203.
29. Padayachee M., Feighery C., Finn A., McKeown C., Levinsky R.J., Kinnon C., et al. Mapping of the X-linked form of hyper-IgM syndrome (HIGM1) to Xq26 by close linkage to HPRT. Genomics 1992, 14:551-553.
30. Korthauer U., Graf D., Mages H.W., Briere F., Padayachee M., Malcolm S., et al. Defective expression of T-cell CD40 ligand causes X-linked immunodeficiency with hyper-IgM. Nature 1993, 361:539-541.
31. DiSanto J.P., Bonnefoy J.Y., Gauchat J.F., Fischer A., de Saint Basile G. CD40 ligand mutations in X-linked immunodeficiency with hyper-IgM. Nature 1993, 361:541-543.
32. Ferrari S., Giliani S., Insalaco A., Al-Ghonaium A., Soresina A.R., Loubser M., et al. Mutations of CD40 gene cause an autosomal recessive form of immunodeficiency with hyper IgM. Proc Natl Acad Sci U S A 2001, 98:12614-12619.
33. Balashov K.E., Smith D.R., Khoury S.J., Hafler D.A., Weiner H.L. Increased interleukin 12 production in progressive multiple sclerosis: induction by activated CD4+ T cells via CD40 ligand. Proc Natl Acad Sci U S A 1997, 94:599-603.
34. Karni A., Koldzic D.N., Bharanidharan P., Khoury S.J., Weiner H.L. IL-18 is linked to raised IFN-gamma in multiple sclerosis and is induced by activated CD4(+) T cells via CD40-CD40 ligand interactions. J Neuroimmunol 2002, 125:134-140.
35. Lleo A., Liao J., Invernizzi P., Zhao M., Bernuzzi F., Ma L., Lanzi G., Ansari A.A., Coppel R.L., Zhang P., Li Y., Zhou Z., Lu Q., Gershwin M.E. Immunoglobulin M levels inversely correlate with CD40 ligand promoter methylation in patients with primary biliary cirrhosis. Hepatology 2011 Aug 24, doi:10.1002/hep.24630. [Electronic publication ahead of print].
36. Oertelt S., Invernizzi P., Selmi C., Podda M., Gershwin M.E. Soluble CD40L in plasma of patients with primary biliary cirrhosis. Ann N Y Acad Sci 2005, 1051:205-210.
37. Rosen F.S., Kevy S.V., Merler E., Janeway C.A., Gitlin D. Recurrent bacterial infections and dysgamma-globulinemia: deficiency of 7S gamma-globulins in the presence of elevated 19S gamma-globulins. Report of two cases. Pediatrics 1961, 28:182-195.
38. Lougaris V., Badolato R., Ferrari S., Plebani A. Hyper immunoglobulin M syndrome due to CD40 deficiency: clinical, molecular, and immunological features. Immunol Rev 2005, 203:48-66.
39. Notarangelo L.D., Duse M., Ugazio A.G. Immunodeficiency with hyper-IgM (HIM). Immunodefic Rev 1992, 3:101-121.
40. Coffman R.L., Lebman D.A., Rothman P. Mechanism and regulation of immunoglobulin isotype switching. Adv Immunol 1993, 54:229-270.
41. Jesus A.A., Duarte A.J., Oliveira J.B. Autoimmunity in hyper-IgM syndrome. J Clin Immunol 2008, 28(Suppl. 1):S62-S66.
42. Levy J., Espanol-Boren T., Thomas C., Fischer A., Tovo P., Bordigoni P., et al. Clinical spectrum of X-linked hyper-IgM syndrome. J Pediatr 1997, 131:47-54.
43. DeKruyff R.H., Gieni R.S., Umetsu D.T. Antigen-driven but not lipopolysaccharide-driven IL-12 production in macrophages requires triggering of CD40. J Immunol 1997, 158:359-366.
44. Hayashi T., Rao S.P., Meylan P.R., Kornbluth R.S., Catanzaro A. Role of CD40 ligand in Mycobacterium avium infection. Infect Immun 1999, 67:3558-3565.
45. Hayward A.R., Levy J., Facchetti F., Notarangelo L., Ochs H.D., Etzioni A., et al. Cholangiopathy and tumors of the pancreas, liver, and biliary tree in boys with X-linked immunodeficiency with hyper-IgM. J Immunol 1997, 158:977-983.
46. Subauste C.S., Wessendarp M., Sorensen R.U., Leiva L.E. CD40-CD40 ligand interaction is central to cell-mediated immunity against Toxoplasma gondii: patients with hyper IgM syndrome have a defective type 1 immune response that can be restored by soluble CD40 ligand trimer. J Immunol 1999, 162:6690-6700.
47. Winkelstein J.A., Marino M.C., Ochs H., Fuleihan R., Scholl P.R., Geha R., et al. The X-linked hyper-IgM syndrome: clinical and immunologic features of 79 patients. Medicine 2003, 82:373-384.
48. Agematsu K., Nagumo H., Shinozaki K., Hokibara S., Yasui K., Terada K., et al. Absence of IgD-CD27(+) memory B cell population in X-linked hyper-IgM syndrome. J Clin Invest 1998, 102:853-860.
49. Courtois G., Smahi A., Reichenbach J., Doffinger R., Cancrini C., Bonnet M., et al. A hypermorphic IkappaBalpha mutation is associated with autosomal dominant anhidrotic ectodermal dysplasia and T cell immunodeficiency. J Clin Invest 2003, 112:1108-1115.
50. Doffinger R., Smahi A., Bessia C., Geissmann F., Feinberg J., Durandy A., et al. X-linked anhidrotic ectodermal dysplasia with immunodeficiency is caused by impaired NF-kappaB signaling. Nat Genet 2001, 27:277-285.
51. Jain A., Ma C.A., Liu S., Brown M., Cohen J., Strober W. Specific missense mutations in NEMO result in hyper-IgM syndrome with hypohydrotic ectodermal dysplasia. Nat Immunol 2001, 2:223-228.
52. Orange J.S., Levy O., Geha R.S. Human disease resulting from gene mutations that interfere with appropriate nuclear factor-kappaB activation. Immunol Rev 2005, 203:21-37.
53. Zonana J., Elder M.E., Schneider L.C., Orlow S.J., Moss C., Golabi M., et al. A novel X-linked disorder of immune deficiency and hypohidrotic ectodermal dysplasia is allelic to incontinentia pigmenti and due to mutations in IKK-gamma (NEMO). Am J Hum Genet 2000, 67:1555-1562.
54. Minegishi Y., Lavoie A., Cunningham-Rundles C., Bedard P.M., Hebert J., Cote L., et al. Mutations in activation-induced cytidine deaminase in patients with hyper IgM syndrome. Clin Immunol 2000, 97:203-210.
55. Quartier P., Bustamante J., Sanal O., Plebani A., Debre M., Deville A., et al. Clinical, immunologic and genetic analysis of 29 patients with autosomal recessive hyper-IgM syndrome due to activation-induced cytidine deaminase deficiency. Clin Immunol 2004, 110:22-29.
56. Notarangelo L.D., Hayward A.R. X-linked immunodeficiency with hyper-IgM (XHIM). Clin Exp Immunol 2000, 120:399-405.
57. Durandy A., Revy P., Imai K., Fischer A. Hyper-immunoglobulin M syndromes caused by intrinsic B-lymphocyte defects. Immunol Rev 2005, 203:67-79.
58. Gulino A.V., Notarangelo L.D. Hyper IgM syndromes. Curr Opin Rheumatol 2003, 15:422-429.
59. Lacroix-Desmazes S., Resnick I., Stahl D., Mouthon L., Espanol T., Levy J., et al. Defective self-reactive antibody repertoire of serum IgM in patients with hyper-IgM syndrome. J Immunol 1999, 162:5601-5608.
60. Seyama K., Kobayashi R., Hasle H., Apter A.J., Rutledge J.C., Rosen D., et al. Parvovirus B19-induced anemia as the presenting manifestation of X-linked hyper-IgM syndrome. J Infect Dis 1998, 178:318-324.
61. Herve M., Isnardi I., Ng Y.S., Bussel J.B., Ochs H.D., Cunningham-Rundles C., et al. CD40 ligand and MHC class II expression are essential for human peripheral B cell tolerance. J Exp Med 2007, 204:1583-1593.
62. Rathmell J.C., Townsend S.E., Xu J.C., Flavell R.A., Goodnow C.C. Expansion or elimination of B cells in vivo: dual roles for CD40- and Fas (CD95)-ligands modulated by the B cell antigen receptor. Cell 1996, 87:319-329.
63. Schimke R.N., Bolano C., Kirkpatrick C.H. Immunologic deficiency in the congenital rubella syndrome. Am J Dis Child 1969, 118:626-633.
64. Palacin P.S., Castilla Y., Garzon P., Figueras C., Castellvi J., Espanol T. Congenital rubella syndrome, hyper-IgM syndrome and autoimmunity in an 18-year-old girl. J Paediatr Child Health 2007, 43:716-718.
65. Ameratunga R., Woon S.T., Koopmans W., French J. Cellular and molecular characterisation of the hyper immunoglobulin M syndrome associated with congenital rubella infection. J Clin Immunol 2009, 29:99-106.
66. Raziuddin S., Assaf H.M., Teklu B. T cell malignancy in Richter's syndrome presenting as hyper IgM. Induction and characterization of a novel CD3+, CD4-, CD8+ T cell subset from phytohemagglutinin-stimulated patient's CD3+, CD4+, CD8+ leukemic T cells. Eur J Immunol 1989, 19:469-474.
67. Petz L.D., Garratty G. Classification and clinical characteristics of autoimmune hemolytic anemias. Immune hemolytic anemias 2004, 61-131. Churchill Livingstone, Philadelphia. 2nd ed. L.D. Petz, G. Garratty (Eds.).
68. Shinoda K., Taki H., Hounoki H., Ogawa R., Sugiyama E., Tobe K. Severe autoimmune hemolytic anemia associated with IgM warm auto-antibodies in primary Sjogren's syndrome. Int J Rheum Dis 2010, 13:94-96.
69. Azuma E., Nishihara H., Hanada M., Nagai M., Hiratake S., Komada Y., et al. Recurrent cold hemagglutinin disease following allogeneic bone marrow transplantation successfully treated with plasmapheresis, corticosteroid and cyclophosphamide. Bone Marrow Transplant 1996, 18:243-246.
70. Gertz M.A. Cold hemolytic syndrome. Hematology Am Soc Hematol Educ Program 2006, 19-23.
71. Brunner B., Kropshofer G., Ellemunter H., Brunner A., Mueller T., Margreiter R., et al. Severe cold agglutinin disease caused by recurrent monomorphic Epstein-Barr virus (EBV)-associated post-transplant lymphoproliferative disorder (PTLD), clonally related to an EBV-negative plasmacytic hyperplasia in a pediatric multivisceral organ transplant recipient. Pediatr Transplant 2007, 11:547-551.
72. Dourakis S.P., Alexopoulou A., Stamoulis N., Foutris A., Pandelidaki H., Archimandritis A.J. Acute Epstein-Barr virus infection in two elderly individuals. Age Ageing 2006, 35:196-198.
73. Khan F.Y., Ayassin M. Mycoplasma pneumoniae associated with severe autoimmune hemolytic anemia: case report and literature review. Braz J Infect Dis 2009, 13:77-79.
74. Lodi G., Resca D., Reverberi R. Fatal cold agglutinin-induced haemolytic anaemia: a case report. J Med Case Reports 2010, 4:252.
75. Mori T., Yamada Y., Aisa Y., Uemura T., Ishida A., Ikeda Y., et al. Cold agglutinin disease associated with adenovirus infection after allogeneic bone marrow transplantation. Bone Marrow Transplant 2005, 36:263-264.
76. Tanaka Y., Masuya M., Katayama N., Miyata E., Sugimoto Y., Shibasaki T., et al. Development of mixed-type autoimmune hemolytic anemia and Evans' syndrome following chicken pox infection in a case of low-titer cold agglutinin disease. Int J Hematol 2006, 84:220-223.
77. Finland M., Peterson O.L., Allen H.E., Samper B.A., Barnes M.W. Cold agglutinins. Ii. Cold isohemagglutinins in primary atypical pneumonia of unknown etiology with a note on the occurrence of hemolytic anemia in these cases. J Clin Invest 1945, 24:458-473.
78. Bretherton L., Toh B.H., Jack I. IgM autoantibody to intermediate filaments in Mycoplasma pneumoniae infections. Clin Immunol Immunopathol 1981, 18:425-430.
79. Ben Aissa-Fennira F., Sassi A., Bouguerra A., Benammar-Elgaaied A. Immunoregulatory role for a public IgM idiotype in the induction of autoimmune diseases in Mycoplasma pneumoniae infection. Immunol Lett 2011, 136:130-137.
80. Havouis S., Dumas G., Chambaud I., Ave P., Huerre M., Blanchard A., et al. Transgenic B lymphocytes expressing a human cold agglutinin escape tolerance following experimental infection of mice by Mycoplasma pulmonis. Eur J Immunol 2002, 32:1147-1156.
81. Brouet J.C., Clauvel J.P., Danon F., Klein M., Seligmann M. Biologic and clinical significance of cryoglobulins. A report of 86 cases. Am J Med 1974, 57:775-788.
82. Morra E. Cryoglobulinemia. Hematology Am Soc Hematol Educ Program 2005, 368-372.
83. Montagnino G. Reappraisal of the clinical expression of mixed cryoglobulinemia. Springer Semin Immunopathol 1988, 10:1-19.
84. Crouzier R., Martin T., Pasquali J.L. Monoclonal IgM rheumatoid factor secreted by CD5-negative B cells during mixed cryoglobulinemia. Evidence for somatic mutations and intraclonal diversity of the expressed VH region gene. J Immunol 1995, 154:413-421.
85. Ferri C. Mixed cryoglobulinemia. Orphanet J Rare Dis 2008, 3:25.
86. Ramos-Casals M., De Vita S., Tzioufas A.G. Hepatitis C virus, Sjogren's syndrome and B-cell lymphoma: linking infection, autoimmunity and cancer. Autoimmun Rev 2005, 4:8-15.
87. Tzioufas A.G., Manoussakis M.N., Costello R., Silis M., Papadopoulos N.M., Moutsopoulos H.M. Cryoglobulinemia in autoimmune rheumatic diseases. Evidence of circulating monoclonal cryoglobulins in patients with primary Sjogren's syndrome. Arthritis Rheum 1986, 29:1098-1104.
88. Mix E., Olsson T., Correale J., Baig S., Kostulas V., Olsson O., et al. B cells expressing CD5 are increased in cerebrospinal fluid of patients with multiple sclerosis. Clin Exp Immunol 1990, 79:21-27.
89. Villar L.M., Espino M., Cavanillas M.L., Roldan E., Urcelay E., de la Concha E.G., et al. Immunological mechanisms that associate with oligoclonal IgM band synthesis in multiple sclerosis. Clin Immunol 2010, 137:51-59.
90. Stauch C., Reiber H., Rauchenzauner M., Strasak A., Pohl D., Hanefeld F., et al. Intrathecal IgM synthesis in pediatric MS is not a negative prognostic marker of disease progression: quantitative versus qualitative IgM analysis. Mult Scler 2011, 17:327-334.
91. Lucchinetti C., Bruck W., Parisi J., Scheithauer B., Rodriguez M., Lassmann H. Heterogeneity of multiple sclerosis lesions: implications for the pathogenesis of demyelination. Ann Neurol 2000, 47:707-717.
92. Hartung H.P., Lehmann H.C., Kieseier B.C., Hughes R.A. Novel treatment for immune neuropathies on the horizon. J Peripher Nerv Syst 2011, 16:75-83.
93. Mayo M.J. Natural history of primary biliary cirrhosis. Clin Liver Dis 2008, 12:277-288. [viii].
94. Leung P.S., Coppel R.L., Ansari A., Munoz S., Gershwin M.E. Antimitochondrial antibodies in primary biliary cirrhosis. Semin Liver Dis 1997, 17:61-69.
95. Bogdanos D.P., Komorowski L. Disease-specific autoantibodies in primary biliary cirrhosis. Clin Chim Acta 2011, 412:502-512.
96. Roberts-Thomson P.J., Shepherd K. Low molecular weight IgM in primary biliary cirrhosis. Gut 1990, 31:88-91.
97. Poupon R., Chazouilleres O., Balkau B., Poupon R.E. Clinical and biochemical expression of the histopathological lesions of primary biliary cirrhosis. UDCA-PBC group. J Hepatol 1999, 30:408-412.
98. Selmi C., Lleo A., Pasini S., Zuin M., Gershwin M.E. Innate immunity and primary biliary cirrhosis. Curr Mol Med 2009, 9:45-51.
99. Higuchi M., Horiuchi T., Kojima T., Nishizaka H., Ishibashi H., Hayashi K., et al. Analysis of CD40 ligand gene mutations in patients with primary biliary cirrhosis. Scand J Clin Lab Invest 1998, 58:429-432.
100. Gray J.D., Horwitz D.A. Activated human NK cells can stimulate resting B cells to secrete immunoglobulin. J Immunol 1995, 154:5656-5664.
101. Santiago-Schwarz F., Kay C., Panagiotopoulos C., Carsons S.E. Rheumatoid arthritis serum or synovial fluid and interleukin 2 abnormally expand natural killer-like cells that are potent stimulators of IgM rheumatoid factor. J Rheumatol 1992, 19:223-228.
102. Hobbs J.R., Milner R.D., Watt P.J. Gamma-M deficiency predisposing to meningococcal septicaemia. Br Med J 1967, 4:583-586.
103. Yocum M.W., Strong D.M., Chusid M.J., Lakin J.D. Selective immunoglobulin M (IgM) deficiency in two immunodeficient adults with recurrent staphylococcal pyoderma. Am J Med 1976, 60:486-494.
104. Inoue T., Okumura Y., Shirama M., Ishibashi H., Kashiwagi S., Okubo H. Selective partial IgM deficiency: functional assessment of T and B lymphocytes in vitro. J Clin Immunol 1986, 6:130-135.
105. De la Concha E.G., Garcia-Rodriguez M.C., Zabay J.M., Laso M.T., Alonso F., Bootello A., et al. Functional assessment of T and B lymphocytes in patients with selective IgM deficiency. Clin Exp Immunol 1982, 49:670-676.
106. Stoelinga G.B., van Munster P.J. Antibody deficiency syndrome and autoimmune haemolytic anaemia in a boy with isolated IgM deficiency dysimmunoglobulinaemia type 5. Acta Paediatr Scand 1969, 58:352-362.
107. Boes M., Schmidt T., Linkemann K., Beaudette B.C., Marshak-Rothstein A., Chen J. Accelerated development of IgG autoantibodies and autoimmune disease in the absence of secreted IgM. Proc Natl Acad Sci U S A 2000, 97:1184-1189.
108. Ehrenstein M.R., Cook H.T., Neuberger M.S. Deficiency in serum immunoglobulin (Ig)M predisposes to development of IgG autoantibodies. J Exp Med 2000, 191:1253-1258.
109. Melegari A., Mascia M.T., Sandri G., Carbonieri A. Immunodeficiency and autoimmune phenomena in female hyper-IgM syndrome. Ann N Y Acad Sci 2007, 1109:106-108.
110. Webster E.A., Khakoo A.Y., Mackus W.J., Karpusas M., Thomas D.W., Davidson A., et al. An aggressive form of polyarticular arthritis in a man with CD154 mutation (X-linked hyper-IgM syndrome). Arthritis Rheum 1999, 42:1291-1296.
111. Imai K., Catalan N., Plebani A., Marodi L., Sanal O., Kumaki S., et al. Hyper-IgM syndrome type 4 with a B lymphocyte-intrinsic selective deficiency in Ig class-switch recombination. J Clin Invest 2003, 112:136-142.
112. Karaca N.E., Durandy A., Gulez N., Aksu G., Kutukculer N. Study of patients with Hyper-IgM type IV phenotype who recovered spontaneously during late childhood and review of the literature. Eur J Pediatr 2011, 170:1039-1047.
113. Durandy A., Taubenheim N., Peron S., Fischer A. Pathophysiology of B-cell intrinsic immunoglobulin class switch recombination deficiencies. Adv Immunol 2007, 94:275-306.
114. Guizar-Vazquez J., Saint-Martin F.P., Rostenberg I., Suarez P.E., Armendares S. Intrafamilial correlation analysis for IgM serum levels. Am J Hum Genet 1977, 29:571-574.
115. Soldan S.S., Berti R., Salem N., Secchiero P., Flamand L., Calabresi P.A., et al. Association of human herpes virus 6 (HHV-6) with multiple sclerosis: increased IgM response to HHV-6 early antigen and detection of serum HHV-6 DNA. Nat Med 1997, 3:1394-1397.
116. Fussey S.P., Ali S.T., Guest J.R., James O.F., Bassendine M.F., Yeaman S.J. Reactivity of primary biliary cirrhosis sera with Escherichia coli dihydrolipoamide acetyltransferase (E2p): characterization of the main immunogenic region. Proc Natl Acad Sci U S A 1990, 87:3987-3991.
117. Bogdanos D.P., Vergani D. Bacteria and primary biliary cirrhosis. Clin Rev Allergy Immunol 2009, 36:30-39.
118. Bogdanos D.P., Baum H., Vergani D., Burroughs A.K. The role of E. coli infection in the pathogenesis of primary biliary cirrhosis. Dis Markers 2010, 29:301-311.
119. Leung P.S., Park O., Matsumura S., Ansari A.A., Coppel R.L., Gershwin M.E. Is there a relation between Chlamydia infection and primary biliary cirrhosis?. Clin Dev Immunol 2003, 10:227-233.